by Megan Redshaw, Childrens Health Defense:

Several girls who participated in the HPV vaccine trials, including some in the placebo group, suffered chronic disabling symptoms, raising questions about the toxic effects of the adjuvant, according to a new study published in the International Journal of Risk & Safety in Medicine.

Merck’s Gardasil clinical trials in Denmark violated medical ethics by needlessly exposing subjects in the placebo group to the company’s proprietary aluminum adjuvant, according to a new study published in the International Journal of Risk & Safety in Medicine.

Children’s Health Defense research consultant Lucija Tomljenovic, Ph.D., and Leemon B. McHenry, Ph.D., bioethicist and professor emeritus of philosophy at California State University Northridge, co-authored the study, which they based on an examination of informed consent and recruitment brochures from Merck’s FUTURE II Gardasil vaccine trials in Denmark.